- Eosinophil-guided steroid duration was noninferior to 5-day therapy.
- Noneosinophilic exacerbations required shorter courses.
- Cumulative steroid exposure was reduced.
- Clinical outcomes were similar between groups.
- No increase in adverse events occurred.
Source: Thorax
